Key facts
- Orca Capital AG filed SCHEDULE 13G/A for Lixte Biotechnology Holdings, Inc. Common Stock, par value $0.0001 per share (LIXT).
- Disclosed ownership: 4.5%.
- Date of event: 14 Feb 2025.
Orca Capital AG - 14 Feb 2025 SCHEDULE 13G/A Report for Lixte Biotechnology Holdings, Inc. Common Stock, par value $0.0001 per share (LIXT)
- Filing Manager
- Orca Capital AG
- Reporting Manager
- Orca Capital AG
- Symbol
- LIXT
- Shares outstanding
- 2,666,933 shares
- Disclosed Ownership
- 120,012 shares
- Ownership
- 4.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 18 Feb 2025, 16:15:05 UTC
- Date of event
- 14 Feb 2025
- Previous filing
- 13 Feb 2025
- SEC
- View on sec.gov
Key filing fact
Orca Capital AG disclosed 4.5% ownership in Lixte Biotechnology Holdings, Inc. Common Stock, par value $0.0001 per share (LIXT) on 14 Feb 2025.
Change
- Previous schedule filing date: 13 Feb 2025.
- Current filing was accepted on 18 Feb 2025, 16:15.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Orca Capital AG | 4.5% | 120,012 | 120,012 | 0 | /s/ Thomas Konig | Thomas Konig/Director |
CIK / CUSIP context first